I
NTLA//CIK 0001652130
Intellia Therapeutics, Inc.
Market Data
$12.69+$2.01 (+18.77%)
NTLA · Last trade
Prev Close
$10.68
Range (29d)
$10.77 – $13.51
Recent Filings
- 1445.1 KBIntellia Therapeutics, Inc.Aug 20, 4:03 PM ET·0001969223-26-000938
- SCHEDULE 13G8.1 KBIntellia Therapeutics, Inc.Aug 7, 9:54 AM ET·0000093751-26-000484
- 10-Q9.9 MBIntellia Therapeutics, Inc.Aug 6, 4:05 PM ET·0001193125-26-337952
- 8-K407.1 KBIntellia Therapeutics, Inc.Aug 6, 7:45 AM ET·0001193125-26-336772
- 8-K291.4 KBIntellia Therapeutics, Inc.Jun 15, 8:52 AM ET·0001193125-26-270358
- 8-K212.6 KBIntellia Therapeutics, Inc.Jun 10, 4:36 PM ET·0001193125-26-265934
- 10-Q9.0 MBIntellia Therapeutics, Inc.May 11, 7:49 AM ET·0001193125-26-215740
- 8-K346.4 KBIntellia Therapeutics, Inc.May 11, 7:36 AM ET·0001193125-26-215721
- 8-K401.0 KBIntellia Therapeutics, Inc.Apr 30, 4:30 PM ET·0001193125-26-197489
- 8-K6.2 MBIntellia Therapeutics, Inc.Apr 27, 9:13 AM ET·0001193125-26-179401
Insiders
10- Atlas Venture Associates IX, LLC10% Owner
- Atlas Venture Associates IX, L.P.10% Owner
- Atlas Venture Fund IX, L.P.10% Owner
- Baker Bros. Advisors (GP) LLCFormer 10% owner
- BAKER BROS. ADVISORS LPFormer 10% owner
- BAKER FELIXFormer 10% owner
- BAKER JULIANFormer 10% owner
- BASTA JAMESEVP, General Counsel
- Bell GraemeEVP, Chief Financial Officer
- Bermingham NessanDirector, President & CEO
Tickers
Addresses
business
40 ERIE STREET SUITE 130
CAMBRIDGE, MA, 02139
mailing
40 ERIE STREET SUITE 130
CAMBRIDGE, MA, 02139